Long-Term Engraftment of Human Natural T Regulatory Cells in NOD/SCID IL2rγcnull Mice by Expression of Human IL-2

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Abraham, Sojan ^a   Pahwa, Rajendra ^b   Ye, Chunting ^a   Choi, Jang gi ^a   Pahwa, Savita ^c   Jaggaiahgari, Shashidhar ^b   Raut, Ashwin ^a   Chen, Shuiping ^a   Manjunath, N ^a   Shankar, Premlata ^a  

^a Texas Tech University Health Sciences Center El Paso   (United States)

^b Max Healthcare   (India)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 2; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL EXPANSION; CONTROLLED STUDY; ENGRAFTMENT; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HYDRODYNAMICS BASED TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; LIVER; LUNG; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; REGULATORY T LYMPHOCYTE; SPLEEN; TH17 CELL;

ADOPTIVE TRANSFER; ANIMALS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GRAFT VS HOST DISEASE; HUMANS; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; PHENOTYPE; PLASMIDS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

ANIMALIA; MUS;

EID: 84871319106     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051832     Document Type: Article

References (24)

1. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, et al. (2001) X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27: 18-20.
2. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, et al. (2001) Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27: 68-73.
3. Sakaguchi S, Yamaguchi T, Nomura T, Ono M, (2008) Regulatory T cells and immune tolerance. Cell 133: 775-787.
4. Scheffold A, Huhn J, Hofer T, (2005) Regulation of CD4+CD25+ regulatory T cell activity: it takes (IL-)two to tango. Eur J Immunol 35: 1336-1341.
5. Pahwa R, Jaggaiahgari S, Pahwa S, Inverardi L, Tzakis A, et al. (2010) Isolation and expansion of human natural T regulatory cells for cellular therapy. J Immunol Methods 363: 67-79.
6. Cao T, Soto A, Zhou W, Wang W, Eck S, et al. (2009) Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD). Cell Immunol 258: 65-71.
7. Hippen KL, Merkel SC, Schirm DK, Sieben CM, Sumstad D, et al. (2011) Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity. Sci Transl Med 3: 83ra41.
8. Nadig SN, Wieckiewicz J, Wu DC, Warnecke G, Zhang W, et al. (2010) In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat Med 16: 809-813.
9. Issa F, Hester J, Goto R, Nadig SN, Goodacre TE, et al. (2010) Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model. Transplantation 90: 1321-1327.
10. Donohue JH, Rosenberg SA, (1983) The fate of interleukin-2 after in vivo administration. J Immunol 130: 2203-2208.
11. Chen Q, Khoury M, Chen J, (2009) Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice. Proc Natl Acad Sci U S A 106: 21783-21788.
12. Koenen HJ, Smeets RL, Vink PM, van Rijssen E, Boots AM, et al. (2008) Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112: 2340-2352.
13. Leveque L, Deknuydt F, Bioley G, Old LJ, Matsuzaki J, et al. (2009) Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells. J Immunother 32: 101-108.
14. Brusko TM, Hulme MA, Myhr CB, Haller MJ, Atkinson MA, (2007) Assessing the in vitro suppressive capacity of regulatory T cells. Immunol Invest 36: 607-628.
15. King M, Pearson T, Shultz LD, Leif J, Bottino R, et al. (2008) A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. Clin Immunol 126: 303-314.
16. Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, et al. (2003) CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 9: 1144-1150.
17. Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S, (2002) Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 196: 389-399.
18. Bluestone JA, Tang Q, Sedwick CE, (2008) T regulatory cells in autoimmune diabetes: past challenges, future prospects. J Clin Immunol 28: 677-684.
19. Kalia V, Sarkar S, Subramaniam S, Haining WN, Smith KA, et al. (2010) Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo. Immunity 32: 91-103.
20. Ferrara JL, Cooke KR, Pan L, Krenger W, (1996) The immunopathophysiology of acute graft-versus-host-disease. Stem Cells 14: 473-489.
21. Brunstein CG, Miller JS, Cao Q, McKenna DH, Hippen KL, et al. (2011) Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 117: 1061-1070.
22. Zhou X, Bailey-Bucktrout SL, Jeker LT, Penaranda C, Martinez-Llordella M, et al. (2009) Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 10: 1000-1007.
23. Rubtsov YP, Niec RE, Josefowicz S, Li L, Darce J, et al. (2010) Stability of the regulatory T cell lineage in vivo. Science 329: 1667-1671.
24. Liu F, Song Y, Liu D, (1999) Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 6: 1258-1266.